Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2022 Dermatology Update

Skip to the end of the Expertise Menu

Q1-2022 Dermatology Update

Dermatology deal activity continues to rebound to pre-pandemic levels as the space benefits from macroeconomic tailwinds driving demand for services. Q1 was especially active from a dealmaking perspective, characterized by a few large, landmark transactions. Forefront Dermatology, one of the largest consolidators in the space, and Epiphany Dermatology, both took on investment from new private equity partners in Q1. For Forefront, Partners Group is their third sponsor since they initially took on investment from Varsity Healthcare Partners in 2014. Anne Arundel Dermatology (now on their second PE partner) also made a splash with the acquisition of Academic Alliance in Dermatology, one of the largest independent practices in the country. Provident expects transaction volume to remain robust, barring any recessionary pressures.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2022/04/Q1-2022-Dermatology-Newsletter.pdf” link=”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.